---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-023367"
form_type: "8-K"
ticker: "GTBP"
cik: "0000109657"
company_name: "GT Biopharma, Inc."
filed_at: "2023-07-05T23:59:59+00:00"
generated_at: "2026-06-13T12:30:43.490576+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# GT Biopharma annual meeting elects four directors, ratifies auditor

## Summary
- Elected directors Michael Breen, Rajesh Shrotriya, Bruce Wendel, and Charles Casamento with majority for votes.
- Ratified Weinberg & Company as independent auditor for 2023: 19,823,634 for, 849,463 against.
- Advisory say-on-pay passed: 8,916,400 for, 2,034,860 against, 13,805 abstain, 9,736,535 broker non-votes.
- Quorum of 55.2% represented at meeting (20,701,600 of 37,493,065 shares outstanding).

## SEC filing metadata
- accession: 0001493152-23-023367
- form_type: 8-K
- ticker: GTBP
- cik: 0000109657
- company_name: GT Biopharma, Inc.
- filed_at: 2023-07-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/109657/000149315223023367/0001493152-23-023367-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/109657/000149315223023367/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-023367
- JSON: https://secwatch.observer/filing/0001493152-23-023367.json
- Plain text: https://secwatch.observer/filing/0001493152-23-023367.txt

## Key facts
- Shareholder Votes
  GT Biopharma, Inc. shareholders approved Non-binding advisory vote endorsing the Registrant's executive compensation at the 2023-06-28 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-28
  source text: For Against Abstain Broker Non-Votes 8,916,400 2,034,860 13,805 9,736,535
  evidence_url: https://www.sec.gov/Archives/edgar/data/109657/000149315223023367/0001493152-23-023367-index.htm
- Shareholder Votes
  GT Biopharma, Inc. shareholders approved Ratification of the appointment of Weinberg & Company, P.A. as the Registrant's independent accountants for the year ending December 31, 2023 at the 2023-06-28 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-28
  source text: For Against Abstain 19,823,634 849,463 28,503
  evidence_url: https://www.sec.gov/Archives/edgar/data/109657/000149315223023367/0001493152-23-023367-index.htm
- Shareholder Votes
  GT Biopharma, Inc. shareholders approved Election of four members of the Board of Directors at the 2023-06-28 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-28
  source text: Director For Withheld Michael Breen 9,817,096 1,147,969 Rajesh Shrotriya, M.D. 9,728,749 1,236,316 Bruce Wendel 7,757,208 3,207,857 Charles J. Casamento 9,266,209 1,698,856
  evidence_url: https://www.sec.gov/Archives/edgar/data/109657/000149315223023367/0001493152-23-023367-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.